About Biosynex

Company Description

Located in Strasbourg (France), the BIOSYNEX Company was born in 2005 and specialises in the design and distribution of rapid tests (RDT). Biosynex is now the French market leader in this field.

Fast and easy to use, these tests are commercialized in France and in some 90 countries through local distributors. By targeting both the public and healthcare professionals, Biosynex provides concrete effective solutions to all the latest public health issues.

Since 2020, Biosynex has been at the forefront of the Covid-19 pandemic, offering innovative screening solutions (serology tests, antigen tests, self tests and PCR).

Year founded

2005

Served area

Worldwide

Headcount

248

Headquarters

22 Boulevard Sébastien Brant, 67400 Illkirch-Graffenstaden – France

Shareholder information

Shares outstanding

10,220,280

IPO

March 21, 2011

Stock exchange(s)

Euronext Paris

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.